Gastric POCUS for Airway Management in Patients Using Glucagon-like Peptide-1 Receptor Agonist (Multicentric)

Recruiting Observational Study
Aspiration Pneumonia
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 90
Sex
Any
Study type
Observational
Participants needed
39 (estimated)
Sponsor
Clinica Universidad de Navarra, Universidad de Navarra · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
1\. Introduction Scheduled surgery requires patients to undergo a preoperative fasting period of at least 6 hours to reduce the risk of perioperative pulmonary aspiration. However, certain medications and conditions may delay gastric emptying, potentially increasing aspiration risk. These include diabetic gastroparesis and the use of glucagon-like peptide-1 (GLP-1) receptor agonists for the treat…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Adults patients ,ASA I-III, taking GLP-1 analog medications, undergoing scheduled surgery. Exclusion Criteria: 1. \- History of esophagogastric pathology or previous abdominal surgery. 2. \- Hiatal hernia/gastroesophageal reflux disease. 3. \- Autonomic nervous system disorder…
Contacts

Carlos Puga Carrasco, MD

0034913531920

cpuga@unav.es

CONTACT

Miguel Angel Fernandez-Vaquero, MD,PhD

0034913531920

mferva7@gmail.com

CONTACT